AU Patent

AU2006239177A1 — Polycyclic carbamoylpyridone derivative having HIV integrase inhibitory activity

Assigned to Shionogi and Co Ltd · Expires 2006-11-02 · 20y expired

What this patent protects

Patent listed against cabotegravir-sodium.

Drugs covered by this patent

cabotegravir-sodium (CABOTEGRAVIR SODIUM)

Patent Metadata

Patent number: AU2006239177A1
Jurisdiction: AU
Classification: —
Expires: 2006-11-02
Drug substance claim: No
Drug product claim: No
Assignee: Shionogi and Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.